FOCAL ONSET SEIZURES
Clinical trials for FOCAL ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURES trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy drug shows promise in cutting seizure frequency
Disease control CompletedThis Phase 3 trial tested whether adding the experimental drug XEN1101 to people's current seizure medications could better control their focal epilepsy. About 380 adults who still had seizures despite taking 1-3 standard medications participated. They took either XEN1101 or a pl…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Experimental drug aims to tame uncontrollable seizures
Disease control CompletedThis study tested whether an investigational drug called RAP-219 can safely reduce seizures in adults with focal epilepsy that doesn't respond well to standard medications. About 30 participants, who already had a special brain-stimulation device implanted, took the drug to see i…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC